Hansa Biopharma AB, (“Hansa” or the “Company”) (NASDAQ Stockholm: HNSA), today announced recruitment and randomization in its US ConfIdeS trial is complete. ConfIdeS is…
U.S. News & World Report, the global authority in rankings and consumer advice, today unveiled the 2024-2025 Best Places to Live in the U.S. The…